|
SH3GLB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.621240E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.259400E-01 |
| Normal-vs-Stage2 |
2.358600E-01 |
| Normal-vs-Stage3 |
5.980200E-02 |
| Normal-vs-Stage4 |
9.093700E-02 |
| Stage1-vs-Stage2 |
6.264800E-01 |
| Stage1-vs-Stage3 |
1.699040E-01 |
| Stage1-vs-Stage4 |
3.483400E-01 |
| Stage2-vs-Stage3 |
6.404800E-01 |
| Stage2-vs-Stage4 |
7.392000E-01 |
| Stage3-vs-Stage4 |
9.103400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.292810E-01 |
| Normal-vs-AfricanAmerican |
8.297000E-01 |
| Normal-vs-Asian |
1.956960E-01 |
| Caucasian-vs-AfricanAmerican |
4.076800E-01 |
| Caucasian-vs-Asian |
9.321400E-01 |
| AfricanAmerican-vs-Asian |
4.443600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.546000E-01 |
| Normal-vs-Female |
1.301020E-01 |
| Male-vs-Female |
4.611200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.854200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.916500E-02 |
| Normal-vs-Age(61-80Yrs) |
5.497700E-02 |
| Normal-vs-Age(81-100Yrs) |
3.961600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.455600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.112000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.073000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.069800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.512800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.823000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.957800E-01 |
| Classical-VS-Follicular |
6.501600E-02 |
| Classical-VS-Other |
2.176800E-01 |
| Classical-VS-Normal |
5.199400E-01 |
| Tall-VS-Follicular |
8.057400E-01 |
| Tall-VS-Other |
5.131200E-01 |
| Tall-VS-Normal |
1.669200E-01 |
| Follicular-VS-Other |
6.512600E-01 |
| Follicular-VS-Normal |
5.027600E-02 |
| Other-VS-Normal |
1.248370E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.708000E-02 |
| Normal-vs-N1 |
6.321600E-02 |
| N0-vs-N1 |
7.466200E-01 |
|
|
